Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 9, 2023, the Company filed a Certificate of Amendment of its Seventh Amended and Restated Certificate of Incorporation (the "Certificate of Amendment") with the Secretary of the State of Delaware, which effected an increase in the Company's authorized shares of common stock, from 1,200,000,000 to 1,700,000,000, par value $0.001 per share. The foregoing description is qualified in its entirety by reference to the full text of the Certificate of Amendment, which is included as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.



Exhibit No. Description

3.1 Certificate of Amendment of the Seventh Amended and Restated


            Certificate of Incorporation of Northwest Biotherapeutics, Inc.

104 Cover Page Interactive Data File (embedded with the Inline XBRL


            document).

© Edgar Online, source Glimpses